Arthur Watson MBA

Arthur was the founder and CEO of Convergent Bioscience Ltd. (Convergent) from 1995 to 2010. Mr. Watson conceived Convergent’s business model, raised capital (angel and VC funding) and assembled the management/development team that took a proof-of-concept to commercial sales creating a high-growth, high-margin, business.

Convergent’s iCE280 Analyzer, emerged as the gold-standard for purity testing of FDA-regulated biopharmaceutical drugs. In 2010, Mr. Watson negotiated the successful acquisition of Convergent by Protein Simple Inc. (Santa Clara, CA) in an all-cash transaction of $14 million.

Arthur holds a BASc in Engineering from the University of Toronto and an MBA from the Richard Ivey School of Business.

Follow on: